Abstract: The invention provides N-propionylsarcosineanilides of the formula: ##STR1## wherein n is an integer of 1 to about 3 and the substituent A which can be the same or different when n is greater than 1 is selected from the group consisting of trifluoromethyl; halogen; nitro; acetyl; a straight-chain or branched alkyl group having 1 to 4 carbon atoms; a straight-chain or branched alkoxy group having 1 to 4 carbon atoms; a straight-chain or branched alkylmercapto group having 1 to 7 carbon atoms; a substituted alkylmercapto group of the formula: ##STR2## wherein n is an integer of 1 or 2, R.sub.1 can represent hydrogen and methyl, and R.sub.2 can represent hydroxyl, and an amino group of the formula:--NR.sub.6 R.sub.7 Vwherein R.sub.6 can represent hydrogen, and methyl, and R.sub.7 can represent methyl, substituted benzyl, and R.sub.6 and R.sub.7, together with the nitrogen, can constitute a substituted pyrrolidine ring; a sulphonyl group of the formula:--SO.sub.2 R.sub.3 IIIwherein R.sub.

Abstract: The present invention is related to the new 2.6-dimethyl-4-(3'-nitrophenyl)-1.4-dihydropyridine-3-carboxylic acid beta-trimethylsilylethyl ester-5-carboxylic acid lower alkyl esters with improved antihypertensive and to a process for the treatment of humans suffering from hypertension with such compounds.

Abstract: (3-Alkylamino-2-hydroxypropoxy)-furan-2-carboxylic acid anilides of the formula: ##STR1## in which R.sub.1 denotes a straight or branched C.sub.1 to C.sub.5 alkyl group or a cyclopropyl or cyclopentyl group, R.sub.2 denotes a hydrogen or halogen atom or a methyl, methoxy, nitro or acetyl group, R.sub.3 denotes a hydrogen or halogen atom or a nitro group and A denotes a single bond or the --CH.sub.2 -- or --CH.dbd.CH-- group, and physiologically tolerated acid addition salts thereof possess .beta.-adrenolytic properties and a low toxicity.

Abstract: Novel n-oleyl derivatives of natural and synthetic phosphatidyl ethanolamines are provided. Such derivatives exhibit antilipemic and antiarteriosclerotic properties and are thus useful in pharmaceutical preparations.

Abstract: An improved process for obtaining highly purified phosphatidylcholines (lecithin) including a high content of essential fatty acids is disclosed. Raw lecithins are first extracted with a lower alcohol of 1 to 3 carbon atoms. The resulting two phases are separated and the alcohol-rich upper phase is treated with an aluminum oxide adsorbent. Elution of the adsorbent with an alcohol (as in known processes) results in an oily phosphatidylcholine, free of cephalin and inositol phosphatides but possessing a high content of essential fatty acids.

Abstract: Structural analogs of natural phospholipids of the general formulae ##STR1## where R.sub.1 and R.sub.2 represent either hydrogen and/or saturated or unsaturated straight-chain and branched acyl radicals with 2 to 24 C-atoms and R.sub.3 an amino group or a substituted amino group of the formula ##STR2## and n is a number from 1-3, are useful in the preparation of stable liposomes useful as vehicles for pharmaceutical preparations.

Abstract: A spreading device for the treatment of hip dysplasties comprises a back support for engagement with a patient's back in the area of the sacrum. From the back support two side portions extend to the front, to each of which a thigh splint in the nature of a leaf spring is connected. The ends of the thigh splints form supporting dishes each to be engaged with a thigh of the patient at or above the ham.

Abstract: Processes for preparing benzoylethers, their acid additive salts and their quaternary ammonium salts are disclosed. These compounds have useful pharmacodynamic properties.

Abstract: A compound of the formula ##STR1## (wherein R.sub.1 and R.sub.2 are each H or a fatty-acid residue, and R.sub.3 is ##STR2## and PG is a prostaglandin radical or optical isomer thereof) is found to have a substantially increased duration of effect, compared with the corresponding prostaglandin per se, and also a strong organ specificity.

Abstract: Lipase is obtained by treating comminuted pancreas tissue with a mixture of 80- 95% by volume (a) halogenated hydrocarbon having a boiling point of 47.degree. - 130.degree. C. and a density greater than 1.3, or (b) hydrocarbon having a boiling point of 47.degree. - 130.degree. C. and a density of from 0.655 to 0.88, and a water immiscible alcohol having 4- 6 carbons.

Abstract: 2-[.alpha.-(2,6-Dichlorophenoxy)-ethyl]-.DELTA..sup.2 -imidazoline, and physiologically acceptable acid addition salts thereof, which provide vasoactivity and hypotensive activity.

Abstract: 2-[.alpha.-(2,6-DICHLOROPHENOXY)-ETHYL]-.DELTA..sup.2 -IMIDAZOLINE, AND PHYSIOLOGICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF, WHICH PROVIDE VASOACTIVITY AND HYPOTENSIVE ACTIVITY.